We honor 100 of the leading innovators in pathology and laboratory medicine by celebrating their success at the cutting edge of the field.
Marloes Smit and Wilma Mesker
Could the tumor-stroma ratio (TSR) yield more accurate reuslts than the tumor-node-metastasis (TMN) system?
Sitting Down With… Richard J. Ablin, Professor of Pathology, University of Arizona College of Medicine
An investigation into PARP1 has given some insight into its link with cancer treatment-resistance
Predicting pancreatic lesion malignancy risk is only an assay away with a PCR-based technique
Research about the underlying pathways of chimeric transplant tolerance may aid immunosuppression
Jesse L. Berry
Taking on the challenge of opening up new opportunities for retinoblastoma care
Kidney tumor with dual cell population, features of emperipolesis, cyclin D1 positivity.
A new grading system for prostate carcinoma – and how you can adopt it in your laboratory
Ian Cree, Head, WHO Classification of Tumors Group, International Agency for Research on Cancer
Mutation of which gene most likely accounts for the pathologic changes seen in this biopsy?
Send me the latest from The Pathologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.